Cell-Easy
Cell therapy CDMO specializing in process development, analytical assays, GMP cell banking, and clinical-scale manufacturing.
Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance. Headquartered in Toulouse, France.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Regulatory clearances
Services
Indications
About this organization
Overview
Cell-Easy is a dedicated cell therapy CDMO founded in 2015, born from direct biotech development experience. The company focuses exclusively on cell therapy manufacturing, combining biology expertise, pharmaceutical know-how, and smart technologies to help academic laboratories, biotechs, and pharma companies overcome development and GMP challenges.
Core Services
- Process Diagnostic & Development: Process development, optimization, and scale-up for cell therapy manufacturing
- Analytical Development: Analytical assay and potency test development
- GMP Cell Banking: Establishment and maintenance of GMP-grade cell banks
- GMP Manufacturing: Full-scale GMP production of cell therapy products
Modalities & Cell Types
Cell-Easy handles 15+ cell types including:
- Immune cells: CAR-T, NK cells, T regulatory cells, non-engineered T cells
- Stem cells: Mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs)
- Immortalized cell lines
Experience spans both autologous and allogeneic therapies, engineered and non-engineered approaches, with applications in immuno-oncology and regenerative medicine.
Regulatory & Quality
The company operates with regulatory compliance at every stage, following ICH Q2 (R1), European Pharmacopeia, EMA/MHRA, and US Pharmacopeia standards. The team has a proven track record of successful regulatory audits and supports clients through the full path to clinic.
Track Record
- 1,000+ clinical doses manufactured in GMP facility
- 50+ active development programs
- Recent clinical milestone: A-MUSE Phase 1/2 trial (allogeneic MSC platform in systemic sclerosis) launched with CHU Toulouse
- €12M Bpifrance grant for iPSC-derived beta cell manufacturing platform
- G-Rex® Grant recipient for European hub development
Locations
Headquarters
Toulouse · Occitanie · France
Related companies
Similar profiles by shared services, modalities, and capabilities.
Cellipont Bioservices- Cell Therapy Manufacturing
- Process Development
Cellistic- Cell Therapy Manufacturing
- Process Development
Pluri- Cell Therapy Manufacturing
- Process Development
Cellares- Cell Therapy Manufacturing
- Process Development
Celularity- Cell Therapy Manufacturing
- Process Development
Cell Therapies- Cell Therapy Manufacturing
- Process Development
Cell and Gene Therapy Catapult- Cell Therapy Manufacturing
- Process Development
Made Scientific- Cell Therapy Manufacturing
- Process Development
Submit a verified review for this organization.
Markdown mirror: /companies/cell-easy.md